Get startedLog in
    Picture of Swedish Orphan Biovitrum AB (publ) logo

    SOBI — Swedish Orphan Biovitrum AB (publ) News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareBalancedLarge CapHigh Flyer
    All News

    Brief: Results From Embrace Phase 2A Study Of Emapalumab In Interferon-Gamma-Driven Sepsis Presented At Isicem

    Picture of Swedish Orphan Biovitrum AB (publ) logoSwedish Orphan Biovitrum AB (publ)
    18/03/2026 11:27
    March 18 (Reuters) - Swedish Orphan Biovitrum AB (publ) SOBIV.ST:

RESULTS FROM EMBRACE PHASE 2A STUDY OF EMAPALUMAB IN INTERFERON-GAMMA-DRIVEN SEPSIS PRESENTED AT ISICEM

Source text: ID:nPreHH8xka

Further company coverage: SOBIV.ST

 ((((Reuters.Briefs@thomsonreuters.com;));))

    Recent news on Swedish Orphan Biovitrum AB (publ)

    See all news